|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
Positron Corporation Positron’s Portable Injection System, Tech-Assist Reduced Radiation Exposure by 50%-75%
Positron Corporation Positron’s Portable Injection System, Tech-Assist Reduced Radiation Exposure by 50%-75%
Positron’s Portable Injection System, Tech-Assist Reduced Radiation Exposure by 50%-75%
Wednesday, 04 March 2009 05:10 | 
| Company News - Positron Corporation |
Positron Corporation announced the results from an independent study on radiation exposure
Positron Corporation (OTCBB:POSC), a Cardiac Molecular Imaging Solutions Company, announced the results from an independent study on radiation exposure of technologists administering FDG. The study was conducted in the Nuclear Medicine Department at Mount Sinai Medical Center in New York, N.Y. by the Director of PET, Ash Rafique. The study compared historic whole body and ring readings using a traditional syringe shield compared to Positron’s Tech-Assist device. The results showed a reduction in whole body badge exposure by 50%-75% and ring badge reductions of 40%-55%, compared to previous month’s data.
Positron’s Tech-Assist is a heavy duty syringe shield (PIG) mounted on a portable cart system. This system is designed to reduce or limit exposure, heavy lifting injuries and repetitive motion injuries that occur during Nuclear Medicine injection applications. The Tech-Assist was designed with the ALARA principles of Time, Distance, and Shielding in mind. The Tech-Assist utilizes tungsten for all shielding. The cart enables the user to transport the PIG to and from the injection room with ease and adjusts to various height levels allowing for the injection of ambulatory or supine patients. . The variable injection head rotates 360° allowing for left or right arm injections and hinges to four different angles creating multiple loading or injecting positions. In additional to significant reduction in radiation exposure the Tech-Assist will improve the comfort and ease of the injection process for the patient as well as for the technologist/nurse.
About Positron Corporation
Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Radiopharmaceutical Products and Molecular Imaging Devices. The Pharmaceutical Products segment offers the world’s first robotic systems (Nuclear Pharm-Assis & Cardio-Assist) for distribution and delivery of radiopharmaceuticals and provides radiopharmaceutical agents used for the diagnosis of cardiac diseases; the Molecular Imaging Devices segment provides PET scanners (Attrius) and SPECT cameras (Pulse);. Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world. Additional information may be found at http://www.positron.com.
Positron’s Tech-Assist is a heavy duty syringe shield (PIG) mounted on a portable cart system. This system is designed to reduce or limit exposure, heavy lifting injuries and repetitive motion injuries that occur during Nuclear Medicine injection applications. The Tech-Assist was designed with the ALARA principles of Time, Distance, and Shielding in mind. The Tech-Assist utilizes tungsten for all shielding. The cart enables the user to transport the PIG to and from the injection room with ease and adjusts to various height levels allowing for the injection of ambulatory or supine patients. . The variable injection head rotates 360° allowing for left or right arm injections and hinges to four different angles creating multiple loading or injecting positions. In additional to significant reduction in radiation exposure the Tech-Assist will improve the comfort and ease of the injection process for the patient as well as for the technologist/nurse.
About Positron Corporation
Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Radiopharmaceutical Products and Molecular Imaging Devices. The Pharmaceutical Products segment offers the world’s first robotic systems (Nuclear Pharm-Assis & Cardio-Assist) for distribution and delivery of radiopharmaceuticals and provides radiopharmaceutical agents used for the diagnosis of cardiac diseases; the Molecular Imaging Devices segment provides PET scanners (Attrius) and SPECT cameras (Pulse);. Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world. Additional information may be found at http://www.positron.com.
Source: Positron Corporation
